Dr. Grekos' office sent this to me.
U.S. Cardiologist Reports Successful Treatment of Cardiovascular Disease Using Patients? Own Adult Stem Cells.
Clinical results presented at international regenerative biomedical technology conference in Dubai.
(Dubai, UAE) In a report unprecedented in the healthcare industry, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage cardiac diseases using Autologous Adult Stem Cell Therapy. Dr. Grekos offered cardiac nuclear scans, PET scans, and echocardiographs performed at six months and one year post-treatment, which confirm the regeneration of damaged heart tissue, the existence of new blood vessels and a dramatic improvement in heart function in patients treated with adult stem cells extracted from their own blood.
?This is real science, real medicine and real results,? Grekos stated. ?We have moved beyond bench research and clinical trials to show that the power of the body?s adult stem cells can be harnessed. Our success rate in reversing ischemic cardiomyopathy and congestive heart failure is extremely high and with our latest technology we?re capturing the same astounding cell regeneration results in other disease classifications.?
Grekos, who is chief medical officer for Florida-based stem cell
center Regenocyte Therapeutic, also announced that his team of physicians and scientists successfully treated a patient with Fabry disease - a previously untreatable enzyme deficiency which leads to heart and kidney failure. The patient?s ejection fraction (EF) increased from 28 to 41 in just four months out from Adult Stem Cell Therapy (normal EF is 55.)
LAO June 17, 2008 LAO October 30, 2008
Above: Nuclear heart function tests before and after Adult Stem Cell Therapy show a 50 percent improvement in heart function in just four months.
According to Dr. Grekos, ?The patient no longer needs a heart transplant, which was previously the only means for arresting this disease. His kidney dialysis time has already been reduced by 10 percent, so we are looking at treating his kidney function in the near future.?
Athina Kyritsis, MD and chair of Regenocyte?s medical advisory committee, states, ?As a physician I find one of the most exciting things this discovery offers is the potential to address many diseases currently believed to be untreatable. We are leaping off of medicine?s cutting edge; this is no longer just theory.?
The Treatment Process
Adult stem cells are extracted from a patient via a standard blood draw. This small, naturally occurring stem cell population is sent to a biotechnology laboratory where it is grown into millions of cells which are engineered to migrate to the part of the body needing repair. The patient receives the new cells one week later through an advanced injection and/or infusion delivery system. Unlike surgically implanted devices, medications, or organ replacement surgery, using a patient's own stem cells to rebuild damaged tissue means there is no possibility of rejection or tumorgenicity (cancer causing).
U.S. Cardiologist Reports Successful Treatment of Cardiovascular Disease Using Patients? Own Adult Stem Cells.
Clinical results presented at international regenerative biomedical technology conference in Dubai.
(Dubai, UAE) In a report unprecedented in the healthcare industry, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage cardiac diseases using Autologous Adult Stem Cell Therapy. Dr. Grekos offered cardiac nuclear scans, PET scans, and echocardiographs performed at six months and one year post-treatment, which confirm the regeneration of damaged heart tissue, the existence of new blood vessels and a dramatic improvement in heart function in patients treated with adult stem cells extracted from their own blood.
?This is real science, real medicine and real results,? Grekos stated. ?We have moved beyond bench research and clinical trials to show that the power of the body?s adult stem cells can be harnessed. Our success rate in reversing ischemic cardiomyopathy and congestive heart failure is extremely high and with our latest technology we?re capturing the same astounding cell regeneration results in other disease classifications.?
Grekos, who is chief medical officer for Florida-based stem cell
center Regenocyte Therapeutic, also announced that his team of physicians and scientists successfully treated a patient with Fabry disease - a previously untreatable enzyme deficiency which leads to heart and kidney failure. The patient?s ejection fraction (EF) increased from 28 to 41 in just four months out from Adult Stem Cell Therapy (normal EF is 55.)
LAO June 17, 2008 LAO October 30, 2008
Above: Nuclear heart function tests before and after Adult Stem Cell Therapy show a 50 percent improvement in heart function in just four months.
According to Dr. Grekos, ?The patient no longer needs a heart transplant, which was previously the only means for arresting this disease. His kidney dialysis time has already been reduced by 10 percent, so we are looking at treating his kidney function in the near future.?
Athina Kyritsis, MD and chair of Regenocyte?s medical advisory committee, states, ?As a physician I find one of the most exciting things this discovery offers is the potential to address many diseases currently believed to be untreatable. We are leaping off of medicine?s cutting edge; this is no longer just theory.?
The Treatment Process
Adult stem cells are extracted from a patient via a standard blood draw. This small, naturally occurring stem cell population is sent to a biotechnology laboratory where it is grown into millions of cells which are engineered to migrate to the part of the body needing repair. The patient receives the new cells one week later through an advanced injection and/or infusion delivery system. Unlike surgically implanted devices, medications, or organ replacement surgery, using a patient's own stem cells to rebuild damaged tissue means there is no possibility of rejection or tumorgenicity (cancer causing).